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Toward adaptive therapies: modeling evolutionary principles in anticancer therapy
Abstract:
Resistance to drug therapy is an important issue in the field of cancer research because, despite
initial success of targeted cancer drugs, many patients will ultimately develop resistance to these
therapies, rendering treatment ineffective. A model of cancer chemotherapy must include both
kinetic resistance (cell-cycle mediated, [1]) and genetic resistance (acquired through random
mutations, [2]) concepts. We present a stochastic Moran process model of tumor cell kinetics,
coupled with a prisoner’s dilemma game-theoretic cell-cell interaction model to design
chemotherapeutic strategies tailored to different tumor growth characteristics [3]. At each step of
the birth-death process, two phenotypic sub-populations compete in a prisoner’s dilemma
evolutionary game with the healthy cells playing the role of cooperators, and the cancer cells
playing the role of defectors. Fitness, birth-death rates of the cell populations, and overall tumor
fitness are defined via the prisoner’s dilemma payoff matrix.
Using the Shannon entropy as a novel tool to quantify dosing strategies, we contrast maximum
tolerated dose (MTD) strategies as compared with low dose, high density metronomic strategies
(LDM) for tumors with different growth rates. Our results show that LDM strategies can
outperform MTD strategies. The advantage is magnified for fast growing tumors that thrive on
long periods of unhindered growth without chemotherapy drugs present and is not evident after a
single cycle of chemotherapy, but grows after each subsequent cycle of repeated chemotherapy.
Finally, we use the model to test various adaptive therapy techniques to exploit the evolutionary
phenotypic cost of developing resistance. We highlight the utility, clarity, and power that models
provide in designing chemotherapeutic schedules for tumors with different growth rates and
develop quantitative tools to optimize these schedules for maintaining low volume tumors.
References:
1. Norton, L and Simon, R. “Tumor size, sensitivity to therapy, and design of treatment
schedules.” Cancer Treatment Reports 61:7 (1977): 1307.
2. Gatenby, Robert A. "A change of strategy in the war on cancer." Nature 459.7246 (2009):
508-509.
3. West, Jeffrey, et al. "The prisoner’s dilemma as a cancer model." Convergent Science Physical
Oncology 2.3 (2016): 035002.

